Provided by Tiger Trade Technology Pte. Ltd.

Elutia

0.8201
+0.04325.56%
Post-market: 0.82010.00000.00%16:10 EDT
Volume:261.02K
Turnover:209.12K
Market Cap:36.26M
PE:0.82
High:0.8398
Open:0.7900
Low:0.7701
Close:0.7769
52wk High:1.39
52wk Low:0.5000
Shares:44.21M
Float Shares:29.44M
Volume Ratio:0.16
T/O Rate:0.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.01
EPS(LYR):0.8700
ROE:--
ROA:-34.66%
PB:2.30
PE(LYR):0.94

Loading ...

Analysts Offer Insights on Healthcare Companies: Elutia (ELUT) and Evaxion Biotech (EVAX)

TIPRANKS
·
Oct 05

Elutia Receives $8 Million Payment from Boston Scientific; Company NOW Fully Funded into 2029

THOMSON REUTERS
·
Oct 02

Elutia: Continues to Expect Favorable FDA Clearance Decision for NXT-41X in H1 2027

THOMSON REUTERS
·
Oct 02

Press Release: Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029

Dow Jones
·
Oct 02

Elutia to Present at H.C. Wainwright Global Investment Conference, Replaces Pre-Recorded Session with Live Webcast

Reuters
·
Sep 11

Elutia to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15th

GlobeNewswire
·
Sep 11

Elutia Executives Attend Lake Street Big Ideas Growth Conference

Reuters
·
Sep 03

Elutia Inc. Earnings Call Highlights Funding, NXT Outlook

TIPRANKS
·
Aug 23

Elutia Divests SimpliDerm to Refocus on NXT-41x

TIPRANKS
·
Aug 22

Elutia Sells SimpliDerm Business to Cellution Biologics for up to $11 Million

Reuters
·
Aug 22

Cellution Biologics completes SimpliDerm acquisition from Elutia

TIPRANKS
·
Aug 18

Cellution Biologics Completes Acquisition of Simpliderm® from Elutia Inc.

THOMSON REUTERS
·
Aug 18

Elutia Completes Sale of SimpliDerm Business to Cellution Biologics for up to $11 Million Cash

Reuters
·
Aug 18

Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch

GlobeNewswire
·
Aug 18

Elutia Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Elutia Q2 EPS $(0.17) Misses $(0.15) Estimate, Sales $2.427M Miss $2.900M Estimate

Benzinga Earnings
·
Aug 14

Elutia - Obtains $15 Mln Credit Facility for NXT-41X

THOMSON REUTERS
·
Aug 14

Elutia Q2 Revenue USD 2.427 Million

THOMSON REUTERS
·
Aug 14

Elutia Secures up to $26 Million to Fund NXT-41X Through Commercial Launch; Reports Second Quarter 2026 Results

THOMSON REUTERS
·
Aug 14

Press Release: Elutia Secures up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results

Dow Jones
·
Aug 14